Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Modified directly observed therapy (MDOT) for injection drug users with HIV disease.

McCance-Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P.

Am J Addict. 2002 Fall;11(4):271-8.

PMID:
12584870
2.

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

Spire B, Lucas GM, Carrieri MP.

Int J Drug Policy. 2007 Aug;18(4):262-70. Epub 2007 Jan 26. Review.

PMID:
17689374
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

HIV treatment as prevention among injection drug users.

Wood E, Milloy MJ, Montaner JS.

Curr Opin HIV AIDS. 2012 Mar;7(2):151-6. doi: 10.1097/COH.0b013e32834f9927. Review.

PMID:
22227587
5.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
6.

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Haddad M, Inch C, Glazier RH, Wilkins AL, Urbshott G, Bayoumi A, Rourke S.

Cochrane Database Syst Rev. 2000;(3):CD001442. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001442.

PMID:
10908497
7.

Antiretroviral therapy for drug users.

Clarke SM, Mulcahy FM.

Int J STD AIDS. 2000 Oct;11(10):627-31. Review.

PMID:
11057932
8.

Drug treatment as HIV prevention: expanding treatment options.

Metzger DS, Zhang Y.

Curr HIV/AIDS Rep. 2010 Nov;7(4):220-5. doi: 10.1007/s11904-010-0059-z. Review.

9.

Oculomotor disturbances in HIV-positive individuals treated with methadone.

Feit J, Kunc M, Walecki P, GorzelaƄczyk EJ.

Postepy Hig Med Dosw (Online). 2014 Dec 4;68:1415-20. Review.

PMID:
25531705

Supplemental Content

Support Center